Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-05-15
1987-02-24
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 85, 546 86, 546 87, A61K 31395, C07D47104
Patent
active
046457739
ABSTRACT:
New .beta.-carboline-3-oxadiazolyl derivatives have the general formula I: ##STR1## wherein X is ##STR2## and wherein R.sup.4, R.sup.A and R have specified meanings. These new compounds exhibit surprising psychotropic properties.
REFERENCES:
patent: 4435403 (1984-03-01), Braestrup et al.
Marjorie et al, Metameconine as a Model Compound in the Study of Aromatic Reactions, Aug. 1962, pp. 2402-2408.
Engelstoft Mogens
Honore Tage
Huth Andreas
Petersen Erling N.
Watjen Frank
Jiles Henry R.
Richter J.
Schering Aktiengesellschaft
LandOfFree
.beta.-carboline-3-oxadiazolyl derivatives, and their use as psy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .beta.-carboline-3-oxadiazolyl derivatives, and their use as psy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta.-carboline-3-oxadiazolyl derivatives, and their use as psy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-109169